[1]
M. Klemm and A. Schrattenholz, “Neurotoxicity of active compounds - establishment of hESC-lines and proteomics technologies forhuman embryo- and neurotoxicity screening and biomarker identification”, ALTEX, vol. 21, no. Supp. 2, pp. 41–48, Jan. 2004.